Michael D Jones

Title: Michael D Jones: Innovator in Antibiotic Production

Introduction

Michael D Jones is a notable inventor based in Indianapolis, IN (US), recognized for his contributions to the field of antibiotic production. With a total of three patents to his name, he has made significant advancements in the development of novel processes and vectors that enhance the efficiency of antibiotic manufacturing.

Latest Patents

One of his latest patents is titled "Process for producing antibiotic A47934." This invention details an improved fermentation process for producing the Gram-positive antibiotic A47934, which involves cultivating a new strain of Streptomyces toyocaensis, NRRL 18112, along with a biologically purified culture of this microorganism. Another significant patent is focused on "Novel cloning vectors containing selectable genetic markers for use in Streptomyces and related organisms." This invention discloses novel recombinant DNA cloning vectors designed for use in Streptomyces, which contain genetic markers that provide antibiotic resistance or colorimetric selectivity to the host cells. The invention also includes transformants of the aforementioned vectors.

Career Highlights

Michael D Jones is currently employed at Eli Lilly and Company, where he continues to innovate in the field of antibiotic research and development. His work has contributed to the advancement of biotechnological methods that are crucial for the production of effective antibiotics.

Collaborations

Some of his notable coworkers include Jeffrey T Fayerman and Nancy E Malin, who have collaborated with him on various projects within the company.

Conclusion

Michael D Jones stands out as a key figure in the field of antibiotic innovation, with his patents reflecting a commitment to improving fermentation processes and genetic engineering techniques. His work at Eli Lilly and Company continues to influence the future of antibiotic production.